CM
BSX icon

Capula Management’s Boston Scientific BSX Stock Holding History

Capula Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3K Buy
+500
New +$27.1K ﹤0.01% 660
2026
Q1 		– Sell
-3,500
Closed -$334K – 1089
2025
Q4 		$334K Sell
3,500
-2,500
-42% -$245K ﹤0.01% 466
2025
Q3 		$586K Buy
6,000
+4,400
+275% +$456K ﹤0.01% 427
2025
Q2 		$172K Buy
1,600
+200
+14% +$20.2K ﹤0.01% 400
2025
Q1 		$141K Buy
+1,400
New +$141K ﹤0.01% 582
2023
Q2 		– Sell
-136,800
Closed -$6.84M – 464
2023
Q1 		$6.84M Sell
136,800
-3,200
-2% -$151K 0.08% 197
2022
Q4 		$6.48M Buy
+140,000
New +$6.06M 0.09% 225
2020
Q1 		– Sell
-6,400
Closed -$289K – 365
2019
Q4 		$289K Sell
6,400
-45,700
-88% -$1.91M 0.01% 336
2019
Q3 		$2.12M Buy
+52,100
New +$2.21M 0.05% 230

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capula Management's BSX Position: Q2 2026 in Review

Capula Management opened a new position in Boston Scientific (BSX) in Q2 2026: 15,222 shares worth $650K. The stake represents ﹤0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Capula Management previously reported a position in BSX as recently as Q4 2025.

Capula Management first reported a position in BSX in Q3 2019 and has held it in 9 quarters since. The position peaked at $821K in Q3 2019. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capula Management held 15,222 shares of Boston Scientific worth $650K as of Q2 2026.
  • Boston Scientific was a new Capula Management position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Capula Management's portfolio in Q2 2026, its #348 holding.
  • Capula Management first reported a position in Boston Scientific in Q3 2019 and has held it in 9 quarters since.
  • Capula Management's Boston Scientific position peaked at $821K in Q3 2019.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capula Management's 13F filing for Q2 2026, filed 14 Aug 2026.